Association of a functional cytochrome P450 4F2 haplotype with urinary 20-HETE and hypertension.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1681/ASN.2007060713PMID 18235092PMCID PMC2390968
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Correlation analysis and identification of G421C in regulatory region of CYP4F2 gene with essential hypertension].

  2006cited by this paper
• Long-term modifications of blood pressure in normotensive and spontaneously hypertensive rats by gene delivery of rAAV-mediated cytochrome P450 arachidonic acid hydroxylase

  2005cited by this paper
• Functional Variant of CYP4A11 20-Hydroxyeicosatetraenoic Acid Synthase Is Associated With Essential Hypertension

  2005cited by this paper
• Urinary 20-Hydroxyeicosatetraenoic Acid Is Associated With Endothelial Dysfunction in Humans

  2004cited by this paper
• Target SNP selection in complex disease association studies

  2004cited by this paper
• MATCHTM: a tool for searching transcription factor binding sites in DNA sequences

  2003cited by this paper
• Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status.

  2002cited by this paper
• P-450 metabolites of arachidonic acid in the control of cardiovascular function.

  2002cited by this paper
• NF-κB1 (p50) Homodimers Contribute to Transcription of thebcl-2 Oncogene*

  2001cited by this paper
• NF-kappaB1 (p50) homodimers contribute to transcription of the bcl-2 oncogene.

  2001cited by this paper
• Molecular Mechanisms of Human Hypertension

  2001cited by this paper
• Functional Consequences of a Polymorphism Affecting NF-κB p50-p50 Binding to the TNF Promoter Region

  2000cited by this paper
• Characterization of human liver leukotriene B(4) omega-hydroxylase P450 (CYP4F2).

  2000cited by this paper
• Formation of 20-Hydroxyeicosatetraenoic Acid, a Vasoactive and Natriuretic Eicosanoid, in Human Kidney

  2000cited by this paper
• Promoter activity and regulation of the CYP4F2 leukotriene B(4) omega-hydroxylase gene by peroxisomal proliferators and retinoic acid in HepG2 cells.

  2000cited by this paper
• Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene.

  1999cited by this paper
• 20-HETE and the kidney: resolution of old problems and new beginnings.

  1999cited by this paper
• Inhibition of renal arachidonic acid ω-hydroxylase activity with ABT reduces blood pressure in the SHR.

  1998cited by this paper
• NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules.

  1997cited by this paper
• Renal P450 metabolites of arachidonic acid and the development of hypertension in Dahl salt-sensitive rats.

  1997cited by this paper
• A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.

  1991cited by this paper
• Isolation of Preferentially Expressed Genes in the Kidneys of Hypertensive Rats

  1991cited by this paper
• Word Count: 4,335 Address correspondence to:

  year unknowncited by this paper

• The biogenesis of potassium transporters: implications of disease-associated mutations

  2024influential citation
• Bioactive lipids in hypertension.

  2023cites this paper
• Urinary 20-HETE: A prospective Non-Invasive prognostic and diagnostic marker for diabetic kidney disease

  2022cites this paper
• Inhibition of 20-hydroxyeicosatetraenoic acid (20-HETE) glucuronidation by non-steroidal anti-inflammatory drugs in human liver microsomes and recombinant UDP-glucuronosyltransferase enzymes.

  2020cites this paper
• Urinary Sediment Transcriptomic and Longitudinal Data to Investigate Renal Function Decline in Type 1 Diabetes

  2020cites this paper
• Exercise training delays renal disorders with decreasing oxidative stress and increasing production of 20-hydroxyeicosatetraenoic acid in Dahl salt-sensitive rats.

  2020cites this paper
• Effects of Ketoconazole, a CYP4F2 Inhibitor, and CYP4F2*3 Genetic Polymorphism on Pharmacokinetics of Vitamin K1

  2019cites this paper
• Detrimental Effects of Testosterone Addition to Estrogen Therapy Involve Cytochrome P-450-Induced 20-HETE Synthesis in Aorta of Ovariectomized Spontaneously Hypertensive Rat (SHR), a Model of Postmenopausal Hypertension

  2018cites this paper
• A Novel Polymorphism in the Promoter of the CYP4A11 Gene Is Associated with Susceptibility to Coronary Artery Disease

  2018cites this paper
• Angiotensin II upregulates CYP4A isoform expression in the rat kidney through angiotensin II type 1 receptor.

  2018cites this paper
• Treatment-Resistant Hypertension: An Update in Device Therapy

  2018cites this paper
• Eicosanoids via CYP450 and cardiovascular disease: Hints from genetic and nutrition studies.

  2018cites this paper
• 20‐HETE in the regulation of vascular and cardiac function

  2018cites this paper
• Conflicting roles of 20-HETE in hypertension and renal end organ damage.

  2018cites this paper
• Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.

  2017cites this paper
• Decoding resistant hypertension signalling pathways.

  2017cites this paper
• Recent developments on the vascular effects of 20-hydroxyeicosatetraenoic acid

  2016cites this paper
• 20-Hydroxyeicosatetraenoic Acid (HETE)-dependent Hypertension in Human Cytochrome P450 (CYP) 4A11 Transgenic Mice

  2016cites this paper
• 20-HETE Activates the Transcription of Angiotensin-Converting Enzyme via Nuclear Factor-κB Translocation and Promoter Binding

  2016cites this paper
• Activates the Transcription of Angiotensin-Converting Enzyme via Nuclear Factor-k B Translocation and Promoter Binding

  2016cites this paper
• 20-Hydroxyeicosatetraenoic Acid (HETE) Dependent Hypertension in Human Cytochrome P450 (CYP) 4A11 Transgenic Mice: Normalization of Blood Pressure by Sodium Restriction, Hydrochlorothiazide, or Blockade of the Type 1 Angiotensin II Receptor

  2016cites this paper
• Androgen-sensitive hypertension associated with soluble guanylate cyclase alpha1 deficiency is mediated by 20-HETE

  2015cites this paper
• 20-HETE is Associated with Unfavorable Outcomes in Subarachnoid Hemorrhage Patients

  2015cites this paper
• Deficiency in the Formation of 20-Hydroxyeicosatetraenoic Acid Enhances Renal Ischemia-Reperfusion Injury.

  2015cites this paper
• Cytochrome 4A11 Genetic Polymorphisms Increase Susceptibility to Ischemic Stroke and Associate with Atherothrombotic Events After Stroke in Chinese

  2015influential citation
• PharmGKB summary: very important pharmacogene information for CYP4F2

  2015cites this paper
• C URRENT OPINION Cytochrome P450 eicosanoids in hypertension and renal disease

  2015cites this paper
• 20-HETE Activates the Transcription of Angiotensin Converting Enzyme (ACE) via NF-kB Translocation and Promoter Binding

  2015cites this paper
• Cytochrome P450 eicosanoids in hypertension and renal disease

  2014cites this paper
• Determination of major UDP-glucuronosyltransferase enzymes and their genotypes responsible for 20-HETE glucuronidation[S]

  2014cites this paper
• A Pharmacogenetics-Based Warfarin Maintenance Dosing Algorithm from Northern Chinese Patients

  2014cites this paper
• Role of NSD1 in H2O2-induced GSTM3 suppression.

  2014cites this paper
• 20-HETE and Blood Pressure Regulation: Clinical Implications

  2014cites this paper
• Genetic Polymorphism of Cytochrome P450 4F2, Vitamin E Level and Histological Response in Adults and Children with Nonalcoholic Fatty Liver Disease Who Participated in PIVENS and TONIC Clinical Trials

  2014cites this paper
• Vascular characterization of mice with endothelial expression of cytochrome P450 4F2

  2014cites this paper
• ROLE OF CYTOCHROME P450 FATTY ACID METABOLISM IN THE PATHOPHYSIOLOGY OF SUBARACHNOID HEMORRHAGE

  2014cites this paper
• Urinary CYP eicosanoid excretion correlates with glomerular filtration in African-Americans with chronic kidney disease.

  2014cites this paper
• Association of Common Variants of CYP 4 A 11 and CYP 4 F 2 with Stroke in the Han Chinese Population

  2014cites this paper
• Introgression of Brown Norway CYP4A genes on to the Dahl salt-sensitive background restores vascular function in SS-5(BN) consomic rats.

  2013cites this paper
• Role of the CYP4A/20-HETE pathway in vascular dysfunction of the Dahl salt-sensitive rat.

  2013cites this paper
• CYP4 enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid ω-hydroxylase activities.

  2013cites this paper
• Mechanisms for the prevention of vitamin E excess

  2013cites this paper
• Synergistical effect of 20-HETE and high salt on NKCC2 protein and blood pressure via ubiquitin–proteasome pathway

  2013cites this paper
• Induction of Angiotensin-Converting Enzyme and Activation of the Renin–Angiotensin System Contribute to 20-Hydroxyeicosatetraenoic Acid–Mediated Endothelial Dysfunction

  2012cites this paper
• 20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway.

  2012cites this paper
• Hypertension, cardiovascular risk and polymorphisms in genes controlling the cytochrome P450 pathway of arachidonic acid: A sex-specific relation?

  2012cites this paper
• Disturbed ratio of renal 20-HETE/EETs is involved in androgen-induced hypertension in cytochrome P450 4F2 transgenic mice.

  2012cites this paper
• CYP7A1 genotypes and haplotypes associated with hypertension in an obese Han Chinese population

  2011cites this paper
• Cytochrome P450-derived eicosanoids, inflammation, and atherosclerotic cardiovascular disease

  2011cites this paper
• The role of 20-HETE in androgen-mediated hypertension.

  2011cites this paper
• Genetic factors associated with patient-specific warfarin dose in ethnic Indonesians

  2011cites this paper
• 20-hydroxyeicosatetraenoic acid, endothelial dysfunction and hypertension.

  2011cites this paper
• Evaluation of CMV and KAP promoters for driving the expression of human CYP4F2 in transgenic mice.

  2011cites this paper
• Peripheral and central augmentation indexes in relation to the CYP4F2 polymorphisms in Chinese

  2011cites this paper
• Association of common variants of CYP4A11 and CYP4F2 with stroke in the Han Chinese population

  2010cites this paper
• 20-Hydroxyeicosatetraeonic Acid: A New Target for the Treatment of Hypertension

  2010cites this paper
• Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE.

  2009cites this paper
• Inhibition of 20-Hydroxyeicosatetraenoic Acid Synthesis Using Specific Plant Lignans: In Vitro and Human Studies

  2009cites this paper
• Overexpression of cytochrome P450 4F2 in mice increases 20-hydroxyeicosatetraenoic acid production and arterial blood pressure.

  2009cites this paper
• Letter to the EditorResponse to ‘Overexpression of cytochrome P450 4F2 in mice increases 20-hydroxyeicosatetraenoic acid production and arterial blood pressure’

  2009cites this paper
• Functional single nucleotide polymorphism-1026C/A of inducible nitric oxide synthase gene with increased YY1-binding affinity is associated with hypertension in a Chinese Han population

  2009cites this paper
• The role of 20-hydroxyeicosatetraenoic acid in adrenocorticotrophic hormone and dexamethasone-induced hypertension

  2009cites this paper
• Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies.

  2008cites this paper
• The V433M Variant of the CYP4F2 Is Associated With Ischemic Stroke in Male Swedes Beyond Its Effect on Blood Pressure

  2008cites this paper